-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Emergent BioSolutions Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2010 to 2023.
- Emergent BioSolutions Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $27.9M, a 19.4% decline year-over-year.
- Emergent BioSolutions Inc. annual Depreciation, Depletion and Amortization for 2023 was $125M, a 12.7% decline from 2022.
- Emergent BioSolutions Inc. annual Depreciation, Depletion and Amortization for 2022 was $143M, a 15.8% increase from 2021.
- Emergent BioSolutions Inc. annual Depreciation, Depletion and Amortization for 2021 was $124M, a 147% increase from 2020.
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)